John R Fischer

John R Fischer

Healthcare

PE eyes customer loyalty in skincare brands: 8 deals

Advent International, Bridgepoint, HealthEdge and MPK Equity are among several PE dealmakers eyeing investments in skincare brands.

5 min read · 02 October 2026

Featured

Deal watch: Specialty pharmacy

Predictable revenues are attracting private equity investors to the sector.

2 min read · 01 October 2026

Healthcare

Diagnosing insurance cost concerns

Population changes, sectoral fragmentation and rising spending are creating an opening for private equity in payer services.

4 min read · 01 October 2026

Healthcare

Phoenix, Quad-C, Thoma Bravo target occupational health; Pharmaceutical growth drives May River’s sale of Dickson to Blackstone and Copeland

Preventing illness and injury at work has created demand for occupational health services, which is attracting PE investors; May River Capital’s sale of an environmental monitoring platform to a Blackstone portfolio company; insights on the geriatric Medicare market and a deal that TPG made in the sector.

4 min read · 25 September 2026

Healthcare

PE backs occupational healthcare: 6 deals

Thoma Bravo, NewSpring and Phoenix Equity are among the PE firms investing in occupational healthcare businesses.

4 min read · 25 September 2026

Healthcare

Exclusive: Healthcare-focused PE firm Haelan Capital launches, announces first investment

The PE firm will target founder-led, tech-enabled healthcare service providers in the lower mid-market with EBITDA values of $2 million-$20 million.

3 min read · 22 September 2026

Healthcare

Haelan Capital Partners launches and makes first investment

Haelan Capital will target founder-led, tech-enabled healthcare service businesses in the lower mid-market.

1 min read · 22 September 2026

Healthcare

HealthEdge-backed Veridian closes acquisition of ScarScience brand from Mitchell-Vance Laboratories

The deal strengthens Veridian's position in scar and wound care and extends its reach in plastic surgery, dermatology, and physical therapy.

1 min read · 21 September 2026

Healthcare

Telix Pharmaceuticals to acquire and merge with BlackRock-backed ITM for up to $2.35bn

Telix will pay $1.65 billion in cash upfront for 100 percent of ITM's shares, plus up to $700 million in contingency payments.

2 min read · 21 September 2026

Healthcare

Montagu, Kohlberg, Arlington bet on medical textiles; Increased demand for fertility treatment drives Amulet’s CV of US Fertility

Demand for medical textiles such as wound dressings is on the rise, and PE firms such as Montagu, Kohlberg and Arlington Capital Partners are taking note; Amulet Capital Partners closed a continuation vehicle to recapitalize US Fertility; a new hire at RoundTable Healthcare Partners.

4 min read · 18 September 2026

Showing 11 to 20 of 307 results
1345…31